Abatacept, Cenicriviroc, or Infliximab for Treatment of Adul

This study reports the results of 3 randomized, double-masked, placebo-controlled substudies of abatacept, cenicriviroc, and infliximab plus standard care for C

Related Keywords

United States , University Of Massachusetts , Massachusetts , Texas , Boston , Chapel Hill , Tufts Medical Center , America , William Powderly , Abatacept Substudy , Williamg Powderly , Infliximab Substudy , Cenicriviroc Substudy , Segura Nunez , Danielk Benjamin Jr , Mena Lora , Department Of Health , University Of Kentucky , Washington University In St Louis , Johnson , Merck Co , Development Authority , University Of Washington Medical Center , Department Of Medicine , Technical Resources International Biomedical Advanced Research , Regeneron Pharmaceutical Inc , University Of Arkansas Medical Sciences , Rutgers New Jersey Medical School , Vanderbilt University Medical Center Trial Innovation , Washington University School Of Medicine , Pfizer , University Of Kansas Medical Center , Tulane University Health Science Center , Dompe Pharmaceuticals , Langone Health Tisch Hospital , Translational Sciences , Janssen Pharmaceuticals , Cystic Fibrosis Foundation , Biomedical Advanced Research , University Of Massachusetts Medical Center , Human Services , Office Of The , Gilead Sciences , Syneos Health , Duke University Medical Center , Boston Medical Center , Duke University , Us National Institutes Of Health , National Institutes Of Health , Us Centers For Disease , Genentech , Group Information , Arrowhead Pharmaceuticals , Technical Resources International , Technical Resources International Inc , Duke Clinical Research Institute , Im Study Group Members , Astrazeneca , Ut Health San Antonio , National Center , Division Of Infectious Diseases , Technical Resource International , Novartis , Bristol Myers Squibb , Vanderbilt University Medical Center Recruitment Innovation , Us Department Of Health , Technical Resources International Support For Role , Study Drug , Disease Control , Infectious Diseases , Washington University School , Patelli Lima , Mendivil Tuchia De Tai , Interest Disclosures , Janssen Scientific , Vault Health , United Therapeutics , Dompe Pharmaceutics , Enterprise Therapeutics , Regeneron Pharmaceutical , San Antonio , Technical Resources , Advancing Translational Sciences , Technical Resources International Support , Merck Laboratories , Assistant Secretary , National Institutes , Washington University , Massachusetts Medical Center , Arkansas Medical Sciences , Texas Health Science Center , Kansas Medical Center , Mayo Clinic , Washington Medical Center , Tisch Hospital , Group Members ,